INS and type 2 diabetes mellitus: The INTERFAST (Intermittent Fasting)–2 trial evaluated the efficacy and safety of intermittent fasting for patients with insulin-treated type 2 diabetes and showed that ADF for 12 weeks improved HbA1c, reduced body weight, and led to a total daily decrease in insulin dose [25].